Levetiracetam
- Product NDC
- 68788-7074
- Requested package NDC
- 68788-7074-6
- 11-digit product format
- 687887074
- Labeler code
- 68788
- Product ID
- 68788-7074_d694befc-990d-4ddc-ba85-370acfa4d9a9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levetiracetam
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA078106
- Marketing category
- ANDA
- Marketing start
- 2018-01-02
- Marketing end
- 0000-00-00
- Substance
- LEVETIRACETAM
- Active strength
- 500 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 68788-7074 | 68788-7074-6 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078106-001 | LEVETIRACETAM | LEVETIRACETAM | 250MG | TABLET / ORAL | AB | 2009-02-10 | |
| A078106-002 | LEVETIRACETAM | LEVETIRACETAM | 500MG | TABLET / ORAL | AB | 2009-02-10 | |
| A078106-003 | LEVETIRACETAM | LEVETIRACETAM | 750MG | TABLET / ORAL | AB | 2009-02-10 | |
| A078106-004 | LEVETIRACETAM | LEVETIRACETAM | 1GM | TABLET / ORAL | AB | 2009-02-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078106-001 | AB |
| A078106-002 | AB |
| A078106-003 | AB |
| A078106-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078106-001 | LEVETIRACETAM | 250MG | TABLET / ORAL | AB | 2009-02-10 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078106-002 | LEVETIRACETAM | 500MG | TABLET / ORAL | AB | 2009-02-10 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078106-003 | LEVETIRACETAM | 750MG | TABLET / ORAL | AB | 2009-02-10 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078106-004 | LEVETIRACETAM | 1GM | TABLET / ORAL | AB | 2009-02-10 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078106-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078106-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078106-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078106-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | ed8e88d0-993e-4683-bdcf-31578130d3df | 2024-04-03 | Warnings, Adverse reactions | 078106 ANDA078106 |
| Levetiracetam | LEVETIRACETAM | Solco Healthcare US, LLC | 57f09129-7151-4a75-9d73-9dd32f74ba43 | 2024-03-27 | Warnings, Adverse reactions | 078106 ANDA078106 |
| Levetiracetam | LEVETIRACETAM | Solco Healthcare US, LLC | dd713e60-478c-43cd-b680-ff594a0b3864 | 2024-03-27 | Warnings, Adverse reactions | 078106 ANDA078106 |
| Levetiracetam | LEVETIRACETAM | Prinston Pharmaceutical Inc. | d818ef84-9b3e-434b-92d9-910cfa8af7da | 2020-08-01 | Warnings, Adverse reactions | 078106 ANDA078106 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68788-7074-6 | 68788707406 | 60 TABLET, FILM COATED in 1 BOTTLE (68788-7074-6) | 2018-01-02 | 0000-00-00 | No | No | Current |